{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:34:26Z","timestamp":1787016866722,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"BEIJING HONGYU MEDICAL DEVELOPMENT FOUNDATION","award":["Z610689157351172053"],"award-info":[{"award-number":["Z610689157351172053"]}]},{"DOI":"10.13039\/100032579","name":"BEIJING MEDICAL AWARD FOUNDATION","doi-asserted-by":"crossref","award":["ZkjcD105181352372093212"],"award-info":[{"award-number":["ZkjcD105181352372093212"]}],"id":[{"id":"10.13039\/100032579","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"DOI":"10.1186\/s40246-026-01001-1","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:24:33Z","timestamp":1781191473000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-cell RNA sequencing reveals chemotherapy-induced apoptosis in acute myeloid leukemia via B cell depletion and M2 to M1 macrophage repolarization"],"prefix":"10.1186","volume":"20","author":[{"given":"Di","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lintao","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"issue":"12","key":"1001_CR1","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/cncr.33458","volume":"127","author":"K Sasaki","year":"2021","unstructured":"Sasaki K, Ravandi F, Kadia TM, DiNardo CD, Short NJ, Borthakur G, et al. De novo acute myeloid leukemia: A population-based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017. Cancer. 2021;127(12):2049\u201361.","journal-title":"Cancer"},{"issue":"8","key":"1001_CR2","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/cncr.33477","volume":"127","author":"HM Kantarjian","year":"2021","unstructured":"Kantarjian HM, Kadia TM, DiNardo CD, Welch MA, Ravandi F. Acute myeloid leukemia: Treatment and research outlook for 2021 and the MD Anderson approach. Cancer. 2021;127(8):1186\u2013207.","journal-title":"Cancer"},{"issue":"11","key":"1001_CR3","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.annonc.2024.08.2241","volume":"35","author":"BJ Monk","year":"2024","unstructured":"Monk BJ, Barretina-Ginesta MP, Pothuri B, Vergote I, Graybill W, Mirza MR, et al. Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA\/ENGOT-OV26\/GOG-3012 trial. Annals oncology: official J Eur Soc Med Oncol. 2024;35(11):981\u201392.","journal-title":"Annals oncology: official J Eur Soc Med Oncol"},{"issue":"10393","key":"1001_CR4","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(23)00108-3","volume":"401","author":"CD DiNardo","year":"2023","unstructured":"DiNardo CD, Erba HP, Freeman SD, Wei AH. Acute myeloid leukaemia. Lancet (London England). 2023;401(10393):2073\u201386.","journal-title":"Lancet (London England)"},{"issue":"10","key":"1001_CR5","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1001\/jamaoncol.2024.2662","volume":"10","author":"S Venugopal","year":"2024","unstructured":"Venugopal S, Sekeres MA. Contemporary Management of Acute Myeloid Leukemia: A Review. JAMA Oncol. 2024;10(10):1417\u201325.","journal-title":"JAMA Oncol"},{"issue":"24","key":"1001_CR6","doi-asserted-by":"publisher","first-page":"5565","DOI":"10.1182\/bloodadvances.2021005538","volume":"5","author":"EM Cherry","year":"2021","unstructured":"Cherry EM, Abbott D, Amaya M, McMahon C, Schwartz M, Rosser J, et al. Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia. Blood Adv. 2021;5(24):5565\u201373.","journal-title":"Blood Adv"},{"issue":"2","key":"1001_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/17474086.2021.1876559","volume":"14","author":"S Agarwal","year":"2021","unstructured":"Agarwal S, Kowalski A, Schiffer M, Zhao J, Bewersdorf JP, Zeidan AM. Venetoclax for the treatment of elderly or chemotherapy-ineligible patients with acute myeloid leukemia: a step in the right direction or a game changer? Expert Rev Hematol. 2021;14(2):199\u2013210.","journal-title":"Expert Rev Hematol"},{"issue":"1","key":"1001_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3322\/caac.21873","volume":"75","author":"HM Kantarjian","year":"2025","unstructured":"Kantarjian HM, DiNardo CD, Kadia TM, Daver NG, Altman JK, Stein EM, et al. Acute myeloid leukemia management and research in 2025. Cancer J Clin. 2025;75(1):46\u201367.","journal-title":"Cancer J Clin"},{"key":"1001_CR9","doi-asserted-by":"publisher","first-page":"695865","DOI":"10.3389\/fimmu.2021.695865","volume":"12","author":"D Fu","year":"2021","unstructured":"Fu D, Zhang B, Wu S, Zhang Y, Xie J, Ning W, et al. Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature. Front Immunol. 2021;12:695865.","journal-title":"Front Immunol"},{"issue":"4","key":"1001_CR10","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1158\/2643-3230.BCD-23-0202","volume":"5","author":"C Restelli","year":"2024","unstructured":"Restelli C, Ruella M, Paruzzo L, Tarella C, Pelicci PG, Colombo E. Recent Advances in Immune-Based Therapies for Acute Myeloid Leukemia. Blood cancer discovery. 2024;5(4):234\u201348.","journal-title":"Blood cancer discovery"},{"key":"1001_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1172\/JCI159579","volume":"132","author":"S Rutella","year":"2022","unstructured":"Rutella S, Vadakekolathu J, Mazziotta F, Reeder S, Yau TO, Mukhopadhyay R, et al. Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia. J Clin Investig. 2022;132:21.","journal-title":"J Clin Investig"},{"issue":"4","key":"1001_CR12","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1182\/blood.2022016954","volume":"141","author":"I Iacobucci","year":"2023","unstructured":"Iacobucci I, Witkowski MT, Mullighan CG. Single-cell analysis of acute lymphoblastic and lineage-ambiguous leukemia: approaches and molecular insights. Blood. 2023;141(4):356\u201368.","journal-title":"Blood"},{"issue":"12","key":"1001_CR13","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/s41587-019-0332-7","volume":"37","author":"JM Granja","year":"2019","unstructured":"Granja JM, Klemm S, McGinnis LM, Kathiria AS, Mezger A, Corces MR, et al. Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemia. Nat Biotechnol. 2019;37(12):1458\u201365.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"1001_CR14","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/bjh.14247","volume":"175","author":"N Shiba","year":"2016","unstructured":"Shiba N, Yoshida K, Shiraishi Y, Okuno Y, Yamato G, Hara Y, et al. Whole-exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia. Br J Haematol. 2016;175(3):476\u201389.","journal-title":"Br J Haematol"},{"issue":"6","key":"1001_CR15","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","volume":"176","author":"P van Galen","year":"2019","unstructured":"van Galen P, Hovestadt V, Wadsworth Ii MH, Hughes TK, Griffin GK, Battaglia S, et al. Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity. Cell. 2019;176(6):1265\u2013e8124.","journal-title":"Cell"},{"key":"1001_CR16","doi-asserted-by":"crossref","unstructured":"Gudiseva HV, Vrathasha V, He J, Bungatavula D, Brien O JM, Chavali VRM. Single Cell Sequencing of Induced Pluripotent Stem Cell Derived Retinal Ganglion Cells (iPSC-RGC) Reveals Distinct Molecular Signatures and RGC Subtypes. Genes. 2021;12(12):2015.","DOI":"10.3390\/genes12122015"},{"issue":"22","key":"1001_CR17","first-page":"4100","volume":"37","author":"S Mangiola","year":"2021","unstructured":"Mangiola S, Doyle MA, Papenfuss AT. Interfacing Seurat with the R tidy universe. Bioinf (Oxford England). 2021;37(22):4100\u20137.","journal-title":"Bioinf (Oxford England)"},{"issue":"1","key":"1001_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41467-017-02391-6","volume":"9","author":"M Schubert","year":"2018","unstructured":"Schubert M, Klinger B, Kl\u00fcnemann M, Sieber A, Uhlitz F, Sauer S, et al. Perturbation-response genes reveal signaling footprints in cancer gene expression. Nat Commun. 2018;9(1):20.","journal-title":"Nat Commun"},{"issue":"4","key":"1001_CR19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32(4):381\u20136.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"1001_CR20","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12(1):1088.","journal-title":"Nat Commun"},{"issue":"2","key":"1001_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41592-019-0667-5","volume":"17","author":"R Browaeys","year":"2020","unstructured":"Browaeys R, Saelens W, Saeys Y. NicheNet: modeling intercellular communication by linking ligands to target genes. Nat Methods. 2020;17(2):159\u201362.","journal-title":"Nat Methods"},{"key":"1001_CR22","first-page":"243","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling Tumor Infiltrating Immune Cells with CIBERSORT. Methods in molecular biology. (Clifton NJ). 2018;1711:243\u201359.","journal-title":"(Clifton NJ)"},{"key":"1001_CR23","doi-asserted-by":"crossref","unstructured":"Harrison MS, Driscoll BG, Farnsworth J, Hinton A, Peppi M, McLean W, et al. Automated Western Blot Analysis of Ototoxin-Induced Prestin Burst in the Blood after Cyclodextrin Exposure. Otology neurotology: official publication Am Otological Soc Am Neurotology Soc [and] Eur Acad Otology Neurotology. 2023;44(9):e653\u20139.","DOI":"10.1097\/MAO.0000000000003994"},{"issue":"2","key":"1001_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","volume":"11","author":"H Kantarjian","year":"2021","unstructured":"Kantarjian H, Kadia T, DiNardo C, Daver N, Borthakur G, Jabbour E, et al. Acute myeloid leukemia: current progress and future directions. Blood cancer J. 2021;11(2):41.","journal-title":"Blood cancer J"},{"issue":"1","key":"1001_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1182\/blood.2023022481","volume":"143","author":"F Thol","year":"2024","unstructured":"Thol F, D\u00f6hner H, Ganser A. How I treat refractory and relapsed acute myeloid leukemia. Blood. 2024;143(1):11\u201320.","journal-title":"Blood"},{"issue":"1","key":"1001_CR26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41392-023-01605-2","volume":"8","author":"ZW Huang","year":"2023","unstructured":"Huang ZW, Zhang XN, Zhang L, Liu LL, Zhang JW, Sun YX, et al. STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia. Signal Transduct Target therapy. 2023;8(1):391.","journal-title":"Signal Transduct Target therapy"},{"issue":"1","key":"1001_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s43018-022-00480-0","volume":"4","author":"A Lasry","year":"2023","unstructured":"Lasry A, Nadorp B, Fornerod M, Nicolet D, Wu H, Walker CJ, et al. An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia. Nat cancer. 2023;4(1):27\u201342.","journal-title":"Nat cancer"},{"issue":"1","key":"1001_CR28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.stem.2019.03.021","volume":"25","author":"J Paris","year":"2019","unstructured":"Paris J, Morgan M, Campos J, Spencer GJ, Shmakova A, Ivanova I, et al. Targeting the RNA m(6)A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia. Cell Stem Cell. 2019;25(1):137\u2013e486.","journal-title":"Cell Stem Cell"},{"issue":"12","key":"1001_CR29","first-page":"3009","volume":"110","author":"J Feng","year":"2025","unstructured":"Feng J, Gou J, Wang Y, Wei W, Ma Y, Ren X, et al. Bisecting GlcNAc expression by bone marrow stromal cells modulates TGF-\u03b21-driven macrophage polarization in myeloid leukemias. Haematologica. 2025;110(12):3009\u201321.","journal-title":"Haematologica"},{"issue":"2","key":"1001_CR30","doi-asserted-by":"publisher","first-page":"e008318","DOI":"10.1136\/jitc-2023-008318","volume":"12","author":"S Guo","year":"2024","unstructured":"Guo S, Mohan GS, Wang B, Li T, Daver N, Zhao Y, et al. Paired single-B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cells in acute myeloid leukemia. J Immunother Cancer. 2024;12(2):e008318.","journal-title":"J Immunother Cancer"},{"issue":"2","key":"1001_CR31","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000500315","volume":"143","author":"Y Li","year":"2020","unstructured":"Li Y, You MJ, Yang Y, Hu D, Tian C. The Role of Tumor-Associated Macrophages in Leukemia. Acta Haematol. 2020;143(2):112\u20137.","journal-title":"Acta Haematol"},{"key":"1001_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/cancers10090332","volume":"10","author":"I Nepstad","year":"2018","unstructured":"Nepstad I, Hatfield KJ, Tvedt THA, Reikvam H, Bruserud \u00d8. Clonal Heterogeneity Reflected by PI3K-AKT-mTOR Signaling in Human Acute Myeloid Leukemia Cells and Its Association with Adverse Prognosis. Cancers. 2018;10:9.","journal-title":"Cancers"},{"issue":"1","key":"1001_CR33","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1182\/blood-2007-10-119438","volume":"113","author":"SM Kornblau","year":"2009","unstructured":"Kornblau SM, Tibes R, Qiu YH, Chen W, Kantarjian HM, Andreeff M, et al. Functional proteomic profiling of AML predicts response and survival. Blood. 2009;113(1):154\u201364.","journal-title":"Blood"},{"issue":"1","key":"1001_CR34","first-page":"e140507","volume":"22","author":"A Ranjbar","year":"2023","unstructured":"Ranjbar A, Soltanshahi M, Taghiloo S, Asgarian-Omran H. Glucose Metabolism in Acute Myeloid Leukemia Cell Line Is Regulated via Combinational PI3K\/AKT\/mTOR Pathway Inhibitors. Iran J Pharm research: IJPR. 2023;22(1):e140507.","journal-title":"Iran J Pharm research: IJPR"},{"key":"1001_CR35","doi-asserted-by":"crossref","unstructured":"Tian L, Liu J, Xia GH, Chen BA. RNAi-mediated knockdown of MCM7 gene on CML cells and its therapeutic potential for leukemia. Medical oncology (Northwood, London, England). 2017;34(2):21.","DOI":"10.1007\/s12032-016-0878-x"},{"issue":"3","key":"1001_CR36","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.stem.2021.02.013","volume":"28","author":"CL Jones","year":"2021","unstructured":"Jones CL, Inguva A, Jordan CT. Targeting Energy Metabolism in Cancer Stem Cells: Progress and Challenges in Leukemia and Solid Tumors. Cell Stem Cell. 2021;28(3):378\u201393.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"1001_CR37","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1038\/s41467-022-29283-8","volume":"13","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Zhang Q, Wang T, Xu N, Lu T, Hong W, et al. Assessment of global health risk of antibiotic resistance genes. Nat Commun. 2022;13(1):1553.","journal-title":"Nat Commun"},{"key":"1001_CR38","first-page":"eadj0430","volume-title":"Distinct adipose progenitor cells emerging with age drive active adipogenesis","author":"G Wang","year":"2025","unstructured":"Wang G, Li G, Song A, Zhao Y, Yu J, Wang Y, et al. Distinct adipose progenitor cells emerging with age drive active adipogenesis. Volume 388. New York, NY: Science; 2025. p. eadj0430. 6745."},{"key":"1001_CR39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/cancers14215318","volume":"14","author":"J Carreras","year":"2022","unstructured":"Carreras J, Roncador G, Hamoudi R. Artificial Intelligence Predicted Overall Survival and Classified Mature B-Cell Neoplasms Based on Immuno-Oncology and Immune Checkpoint Panels. Cancers. 2022;14:21.","journal-title":"Cancers"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-026-01001-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-026-01001-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-026-01001-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:57:53Z","timestamp":1787014673000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40246-026-01001-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1001"],"URL":"https:\/\/doi.org\/10.1186\/s40246-026-01001-1","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study obtained the approval from the Ethics Committee of China-Japan Union Hospital of Jilin University (Approval Number: 2025052914), and obtain the informed consent of all patients.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"124"}}